232 related articles for article (PubMed ID: 8211781)
1. [The morphofunctional characteristics of the bone marrow erythroid cells in some forms of the myelodysplastic syndrome].
Sarycheva TG; Tsvetaeva NV; Kozinets GI
Ter Arkh; 1993; 65(7):52-4. PubMed ID: 8211781
[TBL] [Abstract][Full Text] [Related]
2. [Morphological changes in peripheral blood and bone marrow in patients with myelodysplastic syndromes].
Mariańska B; Apel D; Maj S
Acta Haematol Pol; 1991; 22(1):48-53. PubMed ID: 1823967
[TBL] [Abstract][Full Text] [Related]
3. Classification of the myelodysplastic syndromes.
Bennett JM
Clin Haematol; 1986 Nov; 15(4):909-23. PubMed ID: 3471370
[No Abstract] [Full Text] [Related]
4. [Myelodysplastic syndromes].
Sainty D; Horschowski N; Fossat C; Sampol J
Ann Biol Clin (Paris); 1985; 43(6):821-30. PubMed ID: 3914223
[No Abstract] [Full Text] [Related]
5. In vitro stimulation of erythropoiesis by stem cell factor alone in myelodysplastic syndrome patients with elevated endogenous erythropoietin serum levels.
Zwierzina H; Bammer T; Rollinger-Holzinger I; Herold M; Fenaux P; Nüssler V; Hoflehner E; Geissler D
Clin Cancer Res; 1996 Jun; 2(6):1031-8. PubMed ID: 9816264
[TBL] [Abstract][Full Text] [Related]
6. Antiapoptotic role of growth factors in the myelodysplastic syndromes: concordance between in vitro and in vivo observations.
Tehranchi R; Fadeel B; Schmidt-Mende J; Forsblom AM; Emanuelsson E; Jadersten M; Christensson B; Hast R; Howe RB; Samuelsson J; Zhivotovsky B; Hellström-Lindberg E
Clin Cancer Res; 2005 Sep; 11(17):6291-9. PubMed ID: 16144933
[TBL] [Abstract][Full Text] [Related]
7. Marked decreases of total and immature reticulocytes in myelodysplastic syndrome among patients with pancytopenia.
Kabutomori O; Kanakura Y; Iwatani Y
Acta Haematol; 2003; 109(4):212-3. PubMed ID: 12853698
[No Abstract] [Full Text] [Related]
8. Refractory anemia in the elderly.
Gardner FH
Adv Intern Med; 1987; 32():155-75. PubMed ID: 3548248
[TBL] [Abstract][Full Text] [Related]
9. [Clinical, hematologic and developmental characteristics of myelodysplastic syndromes. Study of a group of patients with a long-term follow-up].
Di Giovanni S; Giallonardo P; Costa MP; Carducci P
Recenti Prog Med; 1987 Feb; 78(2):63-8. PubMed ID: 3473582
[No Abstract] [Full Text] [Related]
10. [Monocytosis and myelomonocytic dysplasia in myelodysplastic syndrome].
Neuwirtová R; Malasková V; Steruská M; Indrák K; Vozobulová V; Haber J; Smolíková A; Musilová J; Jelínek J
Vnitr Lek; 1990 Aug; 36(8):738-45. PubMed ID: 2136457
[TBL] [Abstract][Full Text] [Related]
11. Leukocyte alkaline phosphatase score correlation with bone marrow blast percentage in myelodysplastic syndrome.
Lipshitz J; Limaye S; Patel D
Acta Haematol; 2010; 124(3):179-81. PubMed ID: 20962518
[No Abstract] [Full Text] [Related]
12. Characterization of the erythropoiesis in myelodysplasia by means of ferrokinetic studies, in vitro erythroid colony formation and soluble transferrin receptor.
Brada SJ; de Wolf JT; Hendriks D; Louwes H; van den Berg E; Vellenga E
Leukemia; 1998 Mar; 12(3):340-5. PubMed ID: 9529128
[TBL] [Abstract][Full Text] [Related]
13. Factors influencing survival in myelodysplastic syndromes in a Brazilian population: comparison of FAB and WHO classifications.
Lorand-Metze I; Pinheiro MP; Ribeiro E; de Paula EV; Metze K
Leuk Res; 2004 Jun; 28(6):587-94. PubMed ID: 15120935
[TBL] [Abstract][Full Text] [Related]
14. The presence of clonal cell subpopulations in peripheral blood and bone marrow of patients with refractory cytopenia with multilineage dysplasia but not in patients with refractory anemia may reflect a multistep pathogenesis of myelodysplasia.
Cermák J; Belicková M; Krejcová H; Michalová K; Zilovcová S; Zemanová Z; Brezinová J; Sieglová Z
Leuk Res; 2005 Apr; 29(4):371-9. PubMed ID: 15725470
[TBL] [Abstract][Full Text] [Related]
15. Recombinant human erythropoietin in patients with myelodysplastic syndromes.
Schouten HC; Vellenga E; van Rhenen DJ; de Wolf JT; Coppens PJ; Blijham GH
Leukemia; 1991 May; 5(5):432-6. PubMed ID: 2033964
[TBL] [Abstract][Full Text] [Related]
16. Cyclosporin A in myelodysplastic syndrome: a preliminary report.
Dixit A; Chatterjee T; Mishra P; Choudhary DR; Mahapatra M; Saxena R; Choudhry VP
Ann Hematol; 2005 Sep; 84(9):565-8. PubMed ID: 15809884
[TBL] [Abstract][Full Text] [Related]
17. Over-expression of tumor necrosis factor-alpha in bone marrow biopsies from patients with myelodysplastic syndromes: relationship to anemia and prognosis.
Stifter G; Heiss S; Gastl G; Tzankov A; Stauder R
Eur J Haematol; 2005 Dec; 75(6):485-91. PubMed ID: 16313260
[TBL] [Abstract][Full Text] [Related]
18. Pathogenesis and clinical variations in the myelodysplastic syndromes.
Jacobs A; Clark RE
Clin Haematol; 1986 Nov; 15(4):925-51. PubMed ID: 3552349
[No Abstract] [Full Text] [Related]
19. Erythropoiesis in refractory anemia with excess of blast cells.
Vucković J; Ruvidić R; Jovanović V; Pavlović-Kentera V; Pendić S
Acta Med Iugosl; 1986; 40(3):149-65. PubMed ID: 3776680
[No Abstract] [Full Text] [Related]
20. Presence of peripheral blasts in refractory anemia and refractory cytopenia with multilineage dysplasia predicts an unfavourable outcome.
Knipp S; Strupp C; Gattermann N; Hildebrandt B; Schapira M; Giagounidis A; Aul C; Haas R; Germing U
Leuk Res; 2008 Jan; 32(1):33-7. PubMed ID: 17412418
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
